INTERCEPT PHARMACEUTICALS IN

CUSIP: 45845P108 Class: Common Stock

WASHINGTON CAPITAL MANAGEMENT, INC's Holding History (CIK: 0000928566)

Note: Option positions (PUT/CALL) are excluded.

Q2 2017
Shares 2,400 Value ($000) $291 Avg Close — Range —
Q1 2017
Shares 2,400 Value ($000) $271 Avg Close — Range —
Q4 2016
Shares 2,400 Value ($000) $261 Avg Close — Range —
Q3 2016
Shares 2,400 Value ($000) $395 Avg Close — Range —
Q2 2016
Shares 2,400 Value ($000) $342 Avg Close — Range —